265 filings
Page 5 of 14
UPLOAD
GLMD
Galmed Pharmaceuticals Ltd
31 Mar 21
Letter from SEC
12:00am
6-K
GLMD
Galmed Pharmaceuticals Ltd
26 Mar 21
Current report (foreign)
5:11pm
F-3
GLMD
Galmed Pharmaceuticals Ltd
26 Mar 21
Shelf registration (foreign)
4:15pm
20-F
2020 FY
GLMD
Galmed Pharmaceuticals Ltd
Annual report (foreign)
18 Mar 21
11:29am
6-K
GLMD
Galmed Pharmaceuticals Ltd
18 Mar 21
Galmed Pharmaceuticals Provides Business Update and Reports Fourth Quarter and Year End 2020 Financial Results
7:29am
6-K
GLMD
Galmed Pharmaceuticals Ltd
16 Mar 21
Galmed Pharmaceuticals Announces Dosing of First Subject in First in Human Phase 1 Trial of Amilo-5MER
8:38am
6-K
GLMD
Galmed Pharmaceuticals Ltd
18 Feb 21
Galmed Pharmaceuticals Announces Pricing of $10 Million Public Offering of Ordinary Shares
9:26am
424B5
GLMD
Galmed Pharmaceuticals Ltd
18 Feb 21
Prospectus supplement for primary offering
9:20am
6-K
GLMD
Galmed Pharmaceuticals Ltd
16 Feb 21
Current report (foreign)
4:26pm
424B5
GLMD
Galmed Pharmaceuticals Ltd
16 Feb 21
Prospectus supplement for primary offering
7:10am
SC 13G
GLMD
Galmed Pharmaceuticals Ltd
16 Feb 21
Galmed Pharmaceuticals / Nantahala Capital Management ownership change
6:23am
SC 13G/A
Baharaff Allen
12 Feb 21
Galmed Pharmaceuticals / Baharaff Allen ownership change
4:30pm
SC 13G/A
GLMD
Galmed Pharmaceuticals Ltd
12 Feb 21
Galmed Pharmaceuticals / BIOTECHNOLOGY VALUE FUND L P ownership change
4:13pm
6-K
GLMD
Galmed Pharmaceuticals Ltd
26 Jan 21
Galmed Pharmaceuticals Announces Upcoming Publication in JHEP Reports of New Data Supporting Aramchol's Novel Anti-Fibrotic Mechanism of Action
11:01am
SC 13G/A
GLMD
Galmed Pharmaceuticals Ltd
15 Jan 21
Galmed Pharmaceuticals / Ibex Investors ownership change
11:16am
6-K
GLMD
Galmed Pharmaceuticals Ltd
17 Dec 20
Galmed to add Open Label Part to ARMOR Study; First Read-out Expected in Q4 2021
7:06am
6-K
GLMD
Galmed Pharmaceuticals Ltd
12 Nov 20
Galmed Pharmaceuticals Reports Third Quarter 2020 Financial Results
7:00am
6-K
GLMD
Galmed Pharmaceuticals Ltd
9 Nov 20
Galmed and MyBiotics to Collaborate in Development of Bespoke Microbiome Signature for Aramchol
8:30am
6-K
GLMD
Galmed Pharmaceuticals Ltd
9 Sep 20
Gannex and Galmed Expand Development Programs For NASH Through Research Collaboration of
10:03am
6-K
GLMD
Galmed Pharmaceuticals Ltd
14 Aug 20
Current report (foreign)
4:32pm